Opportunities for Typhoid Vaccination in India.
Opportunities for Typhoid Vaccination in India. Indian Pediatr. 2019 Jun 15;56(6):453-458 Authors: Srinivasan M, Sindhu KN, John J, Kang G Abstract Typhoid fever, an infection with potentially life threatening complications, is responsible for 11 to 21 million illness episodes and 145,000 to 161,000 deaths each year globally. India is a high burden country and also faces the challenge of antimicrobial resistance, which further narrows treatment options. This review analyzes the need for typhoid vaccination in India, and appraises the evidence on efficacy, immunogenicity and cost-effectiveness of currently available typhoid vaccines. In 2018, WHO prequalified the first typhoid conjugate vaccine Vi-TT and recommended it for children aged 6-23 months, along with measles vaccine at 9 or 15 months of age through the expanded programme on immunization. With the high endemicity of typhoid in India and the proven cost-effectiveness of the conjugate vaccine, a roll-out of typhoid vaccine should be considered at the earliest. PMID: 31278221 [PubMed - in process]
Publication date: Available online 30 May 2020Source: Medical Journal Armed Forces IndiaAuthor(s): Shuvasish Choudhury, Debojyoti Moulick, Purbajyoti Saikia, Muhammed Khairujjaman Mazumder
Publication date: Available online 30 May 2020Source: Comparative Immunology, Microbiology and Infectious DiseasesAuthor(s): Hai Xu, Yale Niu, Weiming Hong, Weixin Liu, Xiaoxin Zuo, Xi Bao, Changming Guo, Yu Lu, Bihua Deng
Publication date: Available online 30 May 2020Source: Comparative Immunology, Microbiology and Infectious DiseasesAuthor(s): Ahmad Erfanmanesh, Arash Ghalyanchilangeroudi, Donya Nikaein, Hossein Hosseini, Tahereh Mohajerfar
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Hema S. Gopalan, Anoop Misra
Publication date: Available online 30 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Sachin Atre, Sona Deshmukh, Manjusha Kulkarni
Publication date: Available online 30 May 2020Source: Journal of Ayurveda and Integrative MedicineAuthor(s): Charu Sharma, Sachin Bhardwaj
Publication date: Available online 30 May 2020Source: Acta Pharmaceutica Sinica BAuthor(s): Chunting He, Ming Qin, Xun Sun
India has reported more than 8,000 new cases of the coronavirus in a single day, another record high that topped the deadliest week in the country
Analysis of genetic diversity in indian natural populations of drosophila ananassae. Front Biosci (Elite Ed). 2020 Jun 01;12:237-253 Authors: Singh P, Narula P, Azad S Abstract Forty five natural populations of Drosophila ananassae, collected from entire geo-climatic regions of the India were analyzed to determine the distribution of genetic diversity relative to different eco-geographic factors. Quantitative data on the frequencies of three cosmopolitan inversions in the sampled populations were utilized to deduce Nei's gene diversity estimates. Populations were grouped according to the...
In this study, we analyzed the distribution of Mycobacterium species, compare the diagnostic methods, and susceptibilities to anti-tuberculosis drugs of TB isolates. The aim was to document the current status and to provide a frame of reference for future studies. In this study, 278 Mycobacterium species isolated from 7,480 patients between September 2015 and June 2019 were included. Löwenstein-Jensen medium (LJ) and MGIT 960 were used for the isolation of strains. Susceptibility to 1st-line anti-tuberculosis drugs was determined. Positivity rates in clinical samples were as follows: 1.4% for direct microscopic acid-f...